Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

List of USP reference standards related to ATRIPLA

Client Email

Product

ATRIPLA
Tenofovir Disoproxil Fumarate
Emtricitabine
USP

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

ATRIPLA

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 28 USDMF, 12 EU WC, 2 KDMF, 19 NDC API, 19 Listed Suppliers, $ API Reference Price

40 API Suppliers
28 USDMF
12 EU WC
2 KDMF
19 NDC API
19 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

4 API Suppliers

4 API Suppliers

FINISHED DOSAGE FORMULATIONS

195 FDF Dossiers, 58 FDA Orange Book, 40 Europe, 11 Canada, 67 South Africa, 19 Listed Dossiers

195 FDF Dossiers
58 FDA Orange Book
40 Europe
11 Canada
67 South Africa
19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 400MG;300MG;300MG, CAPSULE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 600MG, TABLET;ORAL - 600MG;200MG;300MG

TABLET;ORAL - 400MG;300MG;300MG
CAPSULE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 600MG
TABLET;ORAL - 600MG;200MG;300MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 Seqens, 8 DKSH, 1 Jai Radhe Sales, 10 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 14 BASF, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 12 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 12 Sigachi Industries, 2 The Dow Chemical Company, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

52 Coating Systems & Additives, 49 Fillers, Diluents & Binders, 29 Controlled & Modified Release, 25 Disintegrants & Superdisintegrants, 22 Direct Compression, 21 Thickeners and Stabilizers, 17 Granulation, 17 Lubricants & Glidants, 11 Co-Processed Excipients, 10 Topical, 9 Empty Capsules, 8 Film Formers & Plasticizers, 6 Taste Masking, 5 API Stability Enhancers, 5 Coloring Agents, 5 Solubilizers, 5 Parenteral, 4 Vegetarian Capsules, 4 Emulsifying Agents, 3 Rheology Modifiers, 3 Chewable & Orodispersible Aids, 1 Surfactant & Foaming Agents

52 Coating Systems & Additives
49 Fillers, Diluents & Binders
29 Controlled & Modified Release
25 Disintegrants & Superdisintegrants
22 Direct Compression
21 Thickeners and Stabilizers
17 Granulation
17 Lubricants & Glidants
11 Co-Processed Excipients
10 Topical
9 Empty Capsules
8 Film Formers & Plasticizers
6 Taste Masking
5 API Stability Enhancers
5 Coloring Agents
5 Solubilizers
5 Parenteral
4 Vegetarian Capsules
4 Emulsifying Agents
3 Rheology Modifiers
3 Chewable & Orodispersible Aids
1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 55 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
55 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 24 Finished Drug Prices, 15 Annual Reports

3 US Medicaid Prescriptions
24 Finished Drug Prices
15 Annual Reports

MARKET PLACE

8 APIs, 5 FDF Dossiers

8 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents, 10 Health Canada Patents

10 US Patents
10 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 USP, 5 Others

5 USP
5 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 95 Xls

Filters

Reset all filters

Filters

FILTER :

filter Catalog Number Reset all filters

5 All

01 11234103

02 11234114

03 11234125

04 11234136

05 11234147

filter Description Reset all filters

5 All

01 1Efavirenz (200 mg)

02 1Efavirenz Racemic (20 mg) ((+/-)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one)

03 1Efavirenz Related Compound A (20 mg) ((S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol)

04 1Efavirenz Related Compound B (10 mg) ((S,E)-6-Chloro-4-(2-Cyclopropylvinyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one)

05 1Efavirenz Related Compound C (20 mg) (6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline)

filter CAS Number Reset all filters

5 All

01 1154598-52-4

02 1177530-93-7

03 1209414-27-7

04 1391860-73-4

05 1440124-96-9

BioAnalytical Methods
USP Standards
Others

Product Main Page

01

USP

Formnext Forum

Not Confirmed

USP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Efavirenz Related Compound B (10 mg) ((S,E)-6...

CAS Number : 440124-96-9

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1234147

Current Lot : R01700

Previous Lot : G0L438 (31-JUL-2016)

NDC Code :

Product Web Link

Digital Content

02

USP

Formnext Forum

Not Confirmed

USP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Efavirenz Related Compound C (20 mg) (6-chlor...

CAS Number : 391860-73-4

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1234136

Current Lot : F1L211

Previous Lot : F0I394 (30-JUN-2013)

NDC Code :

Product Web Link

Digital Content

03

USP

Formnext Forum

Not Confirmed

USP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Efavirenz Related Compound A (20 mg) ((S)-2-(...

CAS Number : 209414-27-7

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1234125

Current Lot : R027V0

Previous Lot : F1L237 (30-APR-2016)

NDC Code :

Product Web Link

Digital Content

04

USP

Formnext Forum

Not Confirmed

USP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Efavirenz Racemic (20 mg) ((+/-)-6-Chloro-4-(...

CAS Number : 177530-93-7

Quantity Per Vial :

Price ($) : 630

Catalog Number : 1234114

Current Lot : R061S0

Previous Lot : G0M381 (31-MAY-2018)

NDC Code :

Product Web Link

Digital Content

05

USP

Formnext Forum

Not Confirmed

USP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Efavirenz (200 mg)

CAS Number : 154598-52-4

Quantity Per Vial :

Price ($) : 560

Catalog Number : 1234103

Current Lot : R038U0

Previous Lot : G0L369 (31-MAY-2017)

NDC Code :

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?